SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.730
-0.050 (-2.81%)
At close: Jun 27, 2025, 4:00 PM
1.700
-0.030 (-1.73%)
After-hours: Jun 27, 2025, 5:35 PM EDT
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $16.07 million as of June 27, 2025. Its market cap has decreased by -48.62% in one year.
Market Cap
16.07M
Enterprise Value
9.64M
1-Year Change
-48.62%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $16.07M, a decrease of -87.71%. That is a compound annual growth rate of -38.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 15.70M | -55.16% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.91B |
| Johnson & Johnson | 366.73B |
| AbbVie | 325.99B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 278.84B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.62B |
| AstraZeneca | 215.99B |